Tumor Paru Icd 10

Lung Cancer Wikipedia

2020 ICD-10-CM Diagnosis Code C80.1

2016

2017

2018

2019

2020

Billable/Specific Code

C80.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2020 edition of ICD-10-CM C80.1 became effective on October 1, 2019.
This is the American ICD-10-CM version of C80.1 - other international versions of ICD-10 C80.1 may differ.

Applicable To

Cancer NOS
Cancer unspecified site (primary)
Carcinoma unspecified site (primary)
Malignancy unspecified site (primary)

Type 1 Excludes

Type 1 Excludes Help

A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C80.1. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

secondary malignant neoplasm of unspecified site (
ICD-10-CM Diagnosis Code C79.9
Applicable To
- Metastatic cancer NOS
- Metastatic disease NOS
Type 1 Excludes
- carcinomatosis NOS (C80.0)
- generalized cancer NOS (C80.0)
- malignant (primary) neoplasm of unspecified site (C80.1)
C79.9)

The following code(s) above C80.1 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

Applicable To annotations, or
Code Also annotations, or
Code First annotations, or
Excludes1 annotations, or
Excludes2 annotations, or
Includes annotations, or
Note annotations, or
Use Additional annotations

that may be applicable to C80.1:

C00-D49
2020 ICD-10-CM Range C00-D49
Neoplasms
Note
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Neoplasms
C80
ICD-10-CM Diagnosis Code C80
Type 1 Excludes
- malignant carcinoid tumor of unspecified site (C7A.00)
- malignant neoplasm of specified multiple sites- code to each site
Malignant neoplasm without specification of site

Approximate Synonyms

Adenocarcinoma in adenomatous polyp
Adenocarcinoma metastatic to unspecified site
Cancer
Cancer in childbirth
Cancer in pregnancy
Cancer metastatic to bone
Cancer metastatic to ovary
Cancer metastatic to parotid gland
Cancer metastatic to vagina
Cancer of unknown primary
Cancer related fatigue
Cancer, adenocarcinoma
Cancer, adenocarcinoma in adenomatous polyp
Cancer, adenocarcinoma in villous adenoma
Cancer, germ cell
Cancer, small cell
Cancer, undifferentiated large cell
Dilated cardiomyopathy secondary to malignancy
Dilated cardiomyopathy, due to malignancy
Eaton lambert syndrome
Eaton lambert syndrome due to cancer
Fatigue due to malignant neoplastic disease
Malignant adenomatous neoplasm
Malignant adenomatous neoplasm in villous adenoma
Malignant ascites
Malignant neoplasm
Malignant neoplastic disease
Malignant neoplastic disease in pregnancy
Malignant neoplastic disease postpartum
Muir torre syndrome w benign sebaceous neoplasm
Muir torre syndrome w malignant sebaceous neoplasm
Myelopathy due to malignant neoplastic disease
Myelopathy in malignant neoplasm
Neoplastic pleural effusion
Neuropathy (nerve damage), peripheral paraneoplastic
Paraneoplastic peripheral neuropathy
Pleural effusion due to malignancy
Postpartum cancer (after childbirth)
Primary malignant germ cell tumor
Primary malignant neoplasm
Primary malignant neoplasm of unknown site
Primary malignant neoplasm of unspecified site (clinical)
Primitive neuroectodermal tumor (pnet)
Primitive non central nervous system neuroectodermal tumor
Restrictive cardiomyopathy secondary to malignancy
Restrictive cardiomyopathy, due to malignancy
Secondary adenocarcinoma
Secondary malignant neoplasm of bone
Secondary malignant neoplasm of ovary
Secondary malignant neoplasm of parotid gland
Secondary malignant neoplasm of vagina
Secondary small cell carcinoma of unspecified site
Small cell carcinoma
Small cell carcinoma metastatic to unspecified site
Torr?-muir syndrome with benign sebaceous neoplasm
Torr?-muir syndrome with malignant sebaceous neoplasm
Torrù-muir syndrome with benign sebaceous neoplasm
Undifferentiated large cell primary malignant neoplasm

Clinical Information

A general term for autonomous tissue growth exhibiting morphologic features of malignancy (e.g. Severe atypia, nuclear pleomorphism, tumor cell necrosis, abnormal mitoses, tissue invasiveness) and for which the transformed cell type has not been specifically identified.
A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Malignant cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of malignancy. Carcinoma is a malignancy that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a malignancy that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a malignancy that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are malignancies that begin in the cells of the immune system. Central nervous system cancers are malignancies that begin in the tissues of the brain and spinal cord.
A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), hodgkin and non-hodgkin lymphomas, leukemias, melanomas, and sarcomas.
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Treatment plans may include surgery, radiation and/or chemotherapy. nih: national cancer institute
New abnormal tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease; tumors perform no useful body function and may be benign or malignant; benign neoplasms are a noncancerous growth that does not invade nearby tissue or spread to other parts of the body; malignant neoplasms or cancer show a greater degree of anaplasia and have the properties of invasion and metastasis; neoplasm terms herein do not distinguish between benign or malignant states, use references listed to cover this concept.

ICD-10-CM C80.1 is grouped within Diagnostic Related Group(s) (MS-DRG v37.0):

826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedure with mcc
827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedure with cc
828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedure without cc/mcc
829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedure with cc/mcc
830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedure without cc/mcc
843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc

Convert C80.1 to ICD-9-CM

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change

Code annotations containing back-references to C80.1:

Type 1 Excludes: C76, C79.9
ICD-10-CM Diagnosis Code C76
Type 1 Excludes
- malignant neoplasm of female genitourinary tract NOS (C57.9)
- malignant neoplasm of male genitourinary tract NOS (C63.9)
- malignant neoplasm of lymphoid, hematopoietic and related tissue (C81-C96)
- malignant neoplasm of skin (C44.-)
- malignant neoplasm of unspecified site NOS (C80.1)
ICD-10-CM Diagnosis Code C79.9
Applicable To
- Metastatic cancer NOS
- Metastatic disease NOS
Type 1 Excludes
- carcinomatosis NOS (C80.0)
- generalized cancer NOS (C80.0)
- malignant (primary) neoplasm of unspecified site (C80.1)
Applicable To: Z80.9, Z85.9
ICD-10-CM Diagnosis Code Z80.9
Applicable To
- Conditions classifiable to C80.1
ICD-10-CM Diagnosis Code Z85.9
Applicable To
- Conditions classifiable to C7A.00, C80.1

Diagnosis Index entries containing back-references to C80.1:

Cancer - see also Neoplasm, by site, malignant
- unspecified site C80.1 (primary)
Carcinoma (malignant) - see also Neoplasm, by site, malignant
- unspecified site C80.1 (primary)
Malignancy - see also Neoplasm, malignant, by site
- unspecified site C80.1 (primary)
Sarcomatosis
Tumor - see also Neoplasm, unspecified behavior, by site
- malignant C80.1 - see also Neoplasm, malignant, by site
  - fusiform cell C80.1 (type)
  - giant cell C80.1 (type)
  - mixed NEC C80.1
  - small cell C80.1 (type)
  - spindle cell C80.1 (type)
  - unclassified C80.1